451 related articles for article (PubMed ID: 33066042)
21. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
22. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
23. Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Plemel JR; Manesh SB; Sparling JS; Tetzlaff W
Glia; 2013 Sep; 61(9):1471-87. PubMed ID: 23839973
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis.
Roy R; Alotaibi AA; Freedman MS
CNS Drugs; 2021 Apr; 35(4):385-402. PubMed ID: 33797705
[TBL] [Abstract][Full Text] [Related]
25. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
[TBL] [Abstract][Full Text] [Related]
26. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
27. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
[TBL] [Abstract][Full Text] [Related]
28. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
29. Cellular senescence and failure of myelin repair in multiple sclerosis.
Koutsoudaki PN; Papadopoulos D; Passias PG; Koutsoudaki P; Gorgoulis VG
Mech Ageing Dev; 2020 Dec; 192():111366. PubMed ID: 32991921
[TBL] [Abstract][Full Text] [Related]
30. Remyelinating strategies in multiple sclerosis.
Luessi F; Kuhlmann T; Zipp F
Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
[TBL] [Abstract][Full Text] [Related]
31. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions.
Fard MK; van der Meer F; Sánchez P; Cantuti-Castelvetri L; Mandad S; Jäkel S; Fornasiero EF; Schmitt S; Ehrlich M; Starost L; Kuhlmann T; Sergiou C; Schultz V; Wrzos C; Brück W; Urlaub H; Dimou L; Stadelmann C; Simons M
Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212715
[TBL] [Abstract][Full Text] [Related]
32. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
33. Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors.
Rankin KA; Mei F; Kim K; Shen YA; Mayoral SR; Desponts C; Lorrain DS; Green AJ; Baranzini SE; Chan JR; Bove R
J Neurosci; 2019 Mar; 39(12):2184-2194. PubMed ID: 30696729
[TBL] [Abstract][Full Text] [Related]
34. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
35. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
Nakahara J; Aiso S; Suzuki N
Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis.
Coelho RP; Saini HS; Sato-Bigbee C
Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):139-44. PubMed ID: 19808013
[TBL] [Abstract][Full Text] [Related]
37. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
Sutiwisesak R; Burns TC; Rodriguez M; Warrington AE
Expert Opin Investig Drugs; 2021 Aug; 30(8):857-876. PubMed ID: 34126015
[No Abstract] [Full Text] [Related]
38. Differential activity of transcription factor Sox9 in early and adult oligodendroglial progenitor cells.
Hassel LA; Fröb F; Küspert M; Hillgärtner S; Arnold P; Huang W; Kirchhoff F; Wegner M
Glia; 2023 Aug; 71(8):1890-1905. PubMed ID: 37017184
[TBL] [Abstract][Full Text] [Related]
39. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Xiao L; Guo D; Hu C; Shen W; Shan L; Li C; Liu X; Yang W; Zhang W; He C
Glia; 2012 Jul; 60(7):1037-52. PubMed ID: 22461009
[TBL] [Abstract][Full Text] [Related]
40. Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.
Behrangi N; Heinig L; Frintrop L; Santrau E; Kurth J; Krause B; Atanasova D; Clarner T; Fragoulis A; Joksch M; Rudolf H; Meuth SG; Joost S; Kipp M
Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2204509119. PubMed ID: 36161894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
